MedPath

Evaluation of copper and zinc quantity in saliva, released from copper oxide and zinc oxide nanoparticles coated attachments used for fixed orthodontic treatment in patients having tooth malalignment

Phase 3
Completed
Registration Number
CTRI/2023/08/056249
Lead Sponsor
il
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

1. Patients needing bonding in upper and lower arch with 0.022 slot MBT prescription stainless steel orthodontic brackets and banding in first molars with no other auxiliaries required other than TPA in the maxilla.

2. Patients who do not require therapeutic extraction of teeth

3. Patients willing to give consent to participate in the study

Exclusion Criteria

1. Presence of systemic disease

2. Presence of smoking habit, habit of chewing gums

3. Use of anti-inflammatory or antibiotic medication

4. Patients with history of Copper or Zinc allergy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath